Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply. Sun JK, Glassman AR, Maturi RK. JAMA 2023;329:1796.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun JK, Glassman AR, Maturi RK. Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply. JAMA 2023;329:1796.
PMID: 37219555